Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort studyResearch in context by Florian Moik, Erzsébet Horváth-Puhó, Cihan Ay, Ingrid Pabinger, Frits Mulder, Nick van Es, Henrik Toft Sørensen

Get full text

Discordance and bleeding in critically ill patients with COVID-19 receiving unfractionated heparin: A comparison between aPTT and anti-factor Xa activity level monitoring by Merijn C. Reuland, Thijs F. van Haaps, Pieter O.L.P. Broeren, Nick van Es, Claire E. Dijkslag-van der Laan, Alexander P.J. Vlaar, Michiel Coppens, Marcella C.A. Müller

Get full text

Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands study by Sterre P.E. Willems, Marjon H. Cnossen, Nick van Es, Paul L. den Exter, Ilmar C. Kruis, Karina Meijer, Laurens Nieuwenhuizen, Joline L. Saes, Nicole M.A. Blijlevens, Waander L. van Heerde, Saskia E.M. Schols

Get full text

Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour‐Derived Extracellular Vesicles by Agustin Enciso‐Martinez, Caroline Løppke, Joyce J. Koene, Jade Ebbelaar, Meike van der Geest, Mandy Los, Emma P. E. M. Boerrigter, Robert Dagil, Tobias Gustavsson, Elena E. Vidal‐Calvo, Ton G. van Leeuwen, Roman I. Koning, Nick van Es, Ali Salanti, Edwin van der Pol, Rienk Nieuwland, Mette Ø. Agerbæk, Peter ten Dijke

Get full text